v3.23.1
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Mar. 31, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 3,829 $ 11,009
Short-term investments 367,527 183,909
OMIDRIA contract royalty asset, short-term 28,940 28,797
Receivables, net 10,033 213,221
Prepaid expense and other assets 6,708 6,300
Total current assets 417,037 443,236
OMIDRIA contract royalty asset 119,681 123,425
Right of use assets 21,025 21,762
Property and equipment, net 1,335 1,492
Restricted investments 1,054 1,054
Total assets 560,132 590,969
Current liabilities:    
Accounts payable 6,446 5,989
Accrued expenses 30,821 30,551
Current portion of unsecured convertible senior notes, net 94,554 94,381
Current portion of OMIDRIA royalty obligation 2,943 1,152
Current portion of lease liabilities 4,427 4,310
Total current liabilities 139,191 136,383
Unsecured convertible senior notes, net 221,209 220,906
OMIDRIA royalty obligation 123,057 125,126
Lease liabilities, non-current 21,287 22,426
Other accrued liabilities, non-current 452 444
Commitments and contingencies (Note 10)
Shareholders' equity:    
Preferred stock, par value $0.01 per share, 20,000,000 shares authorized; none issued and outstanding at March 31, 2023 and December 31, 2022
Common stock, par value $0.01 per share, 150,000,000 shares authorized at March 31, 2023 and December 31, 2022; 62,828,765 shares issued and outstanding at March 31, 2023 and December 31, 2022, respectively 628 628
Additional paid-in capital 723,726 720,773
Accumulated deficit (669,418) (635,717)
Total shareholders' equity 54,936 85,684
Total liabilities and shareholders' equity $ 560,132 $ 590,969